Sector portfolio · Growth fund · United States

RTW Investments LLC's Biotech portfolio

RTW Investments LLC has backed 52 Biotech startups in rounds we track, $11B between them, shown by the stage each has reached. The best-funded is Oruka Therapeutics.

52startups backed
4stages
$11Braised between them
Stage not reportedbiggest stage

RTW Investments LLC's whole portfolioRTW Investments LLC's profile

Segment by segment

Stage not reported

27 startups · $5.7B raised

  1. Oruka TherapeuticsOruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.United States$880M
  2. Spyre TherapeuticsSpyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.United States$678M
  3. Immunic TherapeuticsImmunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.United States$400M
  4. Century TherapeuticsCentury Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.United States$385M
  5. Belite BioBelite Bio is a clinical stage biopharmaceutical drug development company.United States$350M
  6. Rocket PharmaceuticalsRocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.United States$340M
  7. Monte Rosa TherapeuticsMonte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.Switzerland$300M
  8. MoonLake ImmunotherapeuticsMoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.Switzerland$275M

Series B

12 startups · $2.5B raised

  1. Kailera TherapeuticsKailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.United States$600M
  2. Windward BioWindward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committedSwitzerland$365M
  3. Stoke TherapeuticsStoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.United States$255M
  4. Mirador TherapeuticsMirador Therapeutics is a clinical-stage precision medicine company based in San Diego, California.United States$250M
  5. Aktis OncologyAktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.United States$175M
  6. Kyverna TherapeuticsKyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.United States$160M
  7. AIRNAAIRNA is a biotechnology company founded in 2021, focused on discovering and developing RNA editing therapeutics.United States$155M
  8. Tenaya TherapeuticsTenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.United States$152M

Series C and later

8 startups · $2.1B raised

  1. Encoded TherapeuticsEncoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.United States$379M
  2. ZLZai LabChina$310M
  3. Beta BionicsBeta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.United States$296M
  4. CORXEL PharmaceuticalsCORXEL Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2019, previously known as JiXing Pharmaceuticals.United States$287M
  5. Science 37Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.United States$236M
  6. NBNuance BiotechNuance Biotech is a pharmaceutical company Based In China.China$201M
  7. Lycia TherapeuticsLycia Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California.United States$182M
  8. Nuance PharmaNuance Pharma is a specialty biopharmaceutical company based in Shanghai, founded in 2014 by Mark Lotter.China$181M

Series A

5 startups · $583M raised

  1. CPCinCor PharmaCinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.United States$275M
  2. Ottimo PharmaOttimo Pharma is a private, clinical-stage biotechnology company based in Sandwich, Kent, United Kingdom.United Kingdom$140M
  3. Alesta TherapeuticsAlesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.Netherlands$67M
  4. Amani TherapeuticsAmani Therapeutics is a biotechnology company based in New York, founded in 2025.United States$60M
  5. RenovacorNo mercado desde 2009, a Renovacor Tintas se diferencia pela fabricação de tintas e revestimentos acrílicos de qualidade que contaUnited States$41M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names RTW Investments LLC as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like RTW Investments LLC?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.